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Abstract HIV-associated neurocognitive disorder
(HAND) is a frequently occurring comorbidity of HIV
infection. Evidence suggests this condition starts sub-
clinical before a progression to a symptomatic stage.
Blood oxygenated level dependent (BOLD) fMRI has
shown to be a sensitive tool to detect abnormal brain
function in an early stage and might therefore be useful
to evaluate the effect of HIV infection on brain func-
tion. An extensive literature search was performed in
June 2015. Eligibility criteria for included studies were
as follows: (1) conducting with HIV-positive patients,
(2) using BOLD fMRI, and (3) including a HIV-
negative control group. A total of 19 studies were in-
cluded in the review including 931 participants.
Differences in activation between HIV-positive and -
negative participants were found when testing multiple
domains, i.e., attention, (working) memory, and espe-
cially executive functioning. Overall, HIV-positive pa-
tients showed hyperactivation in task-related brain
regions despite equal performances as controls. Task
performance was degraded only for the most complex
tasks. A few studies investigated the effect of aging on
fMRI, and most of them found no interaction with HIV
infection. Only three studies evaluated the effect of
combination antiretroviral therapy (cART) on functional
data suggesting an increase in activation with the use of
cART. fMRI is a sensitive instrument to detect subtle
cognitive changes in HIV patients. Open questions re-
main regarding the effects of cART on fMRI and the
effects of aging on fMRI.
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Introduction
In the recent era of combination antiretroviral therapy
(cART), infection with the human immunodeficiency vi-
rus (HIV) has changed from a rapidly fatal disease into a
chronic condition with subsequent comorbidities (Kirk
and Goetz 2009; Murray et al. 2014). One of the most
important comorbidities in HIV-infected patients is cogni-
tive decline, resulting in HIV-associated neurocognitive
disorders (HAND). It is estimated that around 50 % of
all HIV-infected patients has a form of HAND (Heaton
et al. 2010). Moreover, in this aging population, cognitive
disorders are the most worrying aspect of the disease for
the patients themselves. The advances in cART, over the
past decades, have led to a shift in prevalence from the
most severe form of HAND, HIV-associated dementia
(HAD), towards milder forms of neurocognitive disorders
like asymptomatic neurocognitive impairment (ANI) and
mild neurocognitive disorder (MND) (Heaton et al. 2010;
Tan and McArthur 2011; Antinori et al. 2007; McArthur
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et al. 2010). The large proportion of HIV-infected patients
suffering from ANI poses particular challenges for diag-
nosis, because by definition, these patients do not experi-
ence or report symptoms. Diagnosing ANI and other
forms of HAND is important, as a recent study showed
that patients with ANI have a two- to sixfold increased
risk of developing symptomatic cognitive problems as op-
posed to neurocognitive normal patients (Grant et al.
2014). However, there are some debates on the diagnosis
of ANI and whether the neurocognitive decline is not due
to other comorbidities (Nightingale et al. 2014). Sensitive
screening instruments would therefore be a welcome ad-
dition to the diagnostic armamentarium.
Neuropsychological (NP) testing is the primary method
for diagnosing HAND. However, this is time consuming
and may not be sensitive enough to detect subtle
neurocognitive changes, which may underlie the milder
forms of HAND such as ANI (Ances and Hammoud
2014). Several studies have shown that blood oxygenated
level dependent (BOLD) functional magnetic resonance
imaging (fMRI) is more sensitive in detecting abnormal
brain function compared to NP testing (Haley et al. 2011;
Saykin et al. 1999; Sumowski et al. 2012; Sweet et al.
2006). From 2001 onwards, there have been several studies
evaluating the role of fMRI in the detection of neuronal
dysfunction in HIV-infected patients, first focusing on at-
tention and motor functions while later studies investigated
executive functions and fronto-striatal networks (Ernst
et al. 2002; Chang et al. 2001; Schweinsburg et al. 2012;
Plessis et al. 2015). In order to determine whether fMRI
can be used as a diagnostic tool aiding in HAND diagnosis,
it is important to summarize these studies and evaluate
their usefulness in terms of applicability, risk of bias, and
scientific limitations. A meta-analysis and concise system-
atic review was published in 2014, mostly focusing on the
fronto-striatal system and including different forms of
fMRI than BOLD fMRI, the most frequently used form
of fMRI (Plessis et al. 2014). To date, however, no exten-
sive systematic review on solely BOLD fMRI, investigat-
ing all brain networks, and using only studies with a HIV-
negative control group has been published. This can be
explained by the fact that BOLD fMRI is a relatively new
research tool and, as mentioned before, HIV infection only
recently became a chronic infection. In order to properly
appraise the utility of fMRI in chronic HIV infection, it is
important to extensively outline the available data on this
subject. This can serve as a solid fundament for future
research on this promising novelty in the field. Therefore,
the objective of this review is to systematically analyze
studies investigating BOLD fMRI in HIV-positive and -
negative subjects in terms of differences in activation pat-
terns, in order to evaluate the effect of HIV infection on
brain function and the impact of age and medication.
Methods
Search and selection
This systematic review was conducted according to the
Preferred Reporting Items for Systemic review and Meta-
Analysis (PRISMA) framework. The protocol for this study
is included in the international prospective register of system-
atic reviews PROSPERO under registration number
CRD42015015698. Eligibility criteria for the included studies
were as follows: (1) conducting with HIV-positive patients,
(2) using BOLD fMRI, and (3) including a HIV-negative con-
trol group.
A literature search was performed in June 2015 using three
online databases: Embase, PubMed, and the Cochrane data-
bases. The search terms are presented in supplementary doc-
ument 1. Mesh terms were used if available. All time frames
were included because of the novelty of fMRI. We included
only original research papers in English or in Dutch.
Study selection
The first screening of papers for eligibility was done by one
author (CH). Duplicates were identified and removed. A total
of 538 papers were identified. Full text evaluation of the re-
maining studies for eligibility was performed independently
by two authors (CH and JEA). In addition, references of the
identified studies were cross-checked for any additional rele-
vant studies. The process for selecting studies is summarized
in Fig. 1. One reference from cross-checking studies was ex-
cluded because it was a conference report not published in a
core medical journal (Qiu et al. 2011).
Data extraction and validity
Data extraction was performed by two independent authors
(CH and JEA) using a standardized data extraction form.
Inconsistencies between study forms were discussed and,
when appropriate, reviewed by a third author (MV) for ma-
jority decision. Where doubts remained, authors of the origi-
nal paper in question were contacted. Variables included in the
form were study setting, number of patients, patient character-
istics including HIV-specific variables, cART use, co-medica-
tion, substance abuse, and cognitive status, fMRI task used,
form of analysis of fMRI data, and behavioral and fMRI re-
sults. Results were expressed as statistically significant differ-
ences in activation measured by BOLD signal between HIV-
positive and -negative individuals. The statistical inferences
used on fMRI data were summarized or simplified; if a mul-
tiple comparison correction was used, either by family-wise
error or false discovery rate, this was reported, together with
the level of correction (voxel or cluster level) and the p value
used. A risk of bias assessment was performed for each
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individual study using a standardized risk of bias assessment
form (QUADAS-2). In this assessment, we focused on the risk
of bias in inclusion and possible confounders and not specif-
ically on risks involved in the statistical inference of fMRI
data since the latter information is presented in the result
tables.
Analysis
Medians and standard deviations for baseline characteristics
were calculated when needed and when data was available.
The results were grouped per form of analysis (whole brain or
regions of interest) and furthermore by pairing studies that
investigated the effect of HIV infection on the characteristics
of the BOLD signal and those who specifically studied the
interaction of HIV and aging.
Role of the funding source
There was no role of the funding source in study design, in
collection, analysis, and interpretation of data, in the writing of
the report, or in the decision to submit the paper for
publication.
Results
A total of 538 studies were identified after searching Embase,
PubMed, and Cochrane databases, of which 12 were eligible
for inclusion after screening the title and abstract. Reasons for
exclusion and further process of study selection are depicted
in Fig. 1. Finally, after cross-checking references of the includ-
ed studies, another seven publications were included leading
to 19 manuscripts in the final selection.
Study characteristics
A summary of study characteristics is given in Table 1. All
studies took place in the USA (Ernst et al. 2002; Chang et al.
2001; Schweinsburg et al. 2012; Caldwell et al. 2014; Thomas
et al. 2013; Ances et al. 2011; Ernst et al. 2009; Melrose et al.
2008; Chang et al. 2013; Ances et al. 2008; Chang et al. 2008;
Juengst et al. 2007; Maki et al. 2009; Chang et al. 2004;
Fig. 1 Process of study selection.
BOLD blood oxygenated level
dependent, fMRI functional MRI




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































24 J. Neurovirol. (2017) 23:20–32
Castelo et al. 2006; Ances et al. 2010a; Ortega et al. 2015;
Ipser et al. 2015), except for one, which was situated in South
Africa (Plessis et al. 2015). With only two (12 %) longitudinal
studies (Ances et al. 2011; Ernst et al. 2009), the majority
(78 %) was cross-sectional in design. In total, 19 studies in-
cluded a total of 573 HIV-positive and 408 HIV-negative pa-
tients. Most of the patients were male, with six studies having
solely male participants (Ernst et al. 2002; Chang et al. 2001;
Melrose et al. 2008; Chang et al. 2013; Chang et al. 2008;
Castelo et al. 2006). The mean age of all participants was
41.4 years (95 % CI 41.06–41.64). The majority of HIV pa-
tients were on cARTwith only the South African study having
no patients on cART (Plessis et al. 2015). Two studies did not
report cART use, and average cART use was 56 % (95 % CI
53–58) in the other studies. Four studies specified the type of
cART used and/or gave information on its CNS penetration
effectiveness score (Ernst et al. 2002; Chang et al. 2001;
Ances et al. 2008; Chang et al. 2008). Seven studies included
patients with cognitive deficits ranging from mild impairment
to HAD, either according to the former criteria or the new
Frascati criteria (Chang et al. 2001; Thomas et al. 2013;
Melrose et al. 2008; Chang et al. 2013; Ances et al. 2008;
Juengst et al. 2007; Chang et al. 2004).
Critical appraisal
All studies were appraised for risk of bias on four items (pa-
tient selection, index test, reference standard, and flow and
timing) and for applicability on three items (patient selection,
index test, and reference standard) (supplementary document
2). There were four studies that did not use a reference stan-
dard (NPA) and therefore could not be completely assessed
(Chang et al. 2001; Schweinsburg et al. 2012; Juengst et al.
2007; Castelo et al. 2006; Ances et al. 2010a). The lack of a
reference standard would normally be an issue; however, it
seems surmountable in this setting where the index test, i.e.,
fMRI, might be more sensitive than the reference standard.
There were only four studies (24 %) that scored inadequate
on more than one item, indicating that the risk of bias on the
aforement ioned i tems seems low across s tudies
(Schweinsburg et al. 2012; Caldwell et al. 2014; Chang et al.
2013; Chang et al. 2008).
Impact of HIV on BOLD characteristics
First, studies investigating the influence of HIV infection on
the shape or the response of the BOLD signal were analyzed,
since HIV replication in the brain has been shown to cause
alterations in brain metabolism which might influence signal
intensity (Roc et al. 2007). The BOLD signal depends on the
hemodynamic response of the brain, which causes a greater
delivery of oxygen-rich blood to active neurons as opposed to
inactive neurons. Four studies investigated the effect of HIV
on the characteristics of the BOLD signal (Ances et al. 2011;
Juengst et al. 2007; Ances et al. 2010a; Ances et al. 2010b).
Two of them found no significant difference in mean peak
values of the hemodynamic response function (an indication
of the shape and amplitude of the BOLD signal) when using a
motor task in HIV-positive and HIV-negative subjects
(Table 2) (Ances et al. 2008; Juengst et al. 2007). The third
study, by Ances et al. (2010a, b), using a visual task, found
reduced functional changes in BOLD signal in the visual cor-
tex in HIV-positive subjects as opposed to HIV-negative sub-
jects (Ances et al. 2010a). Finally, using the same task, Ances
et al. (2011) found in a subsequent study a statistically signif-
icant decrease in BOLD signal after 1 year in the HIV-positive
group (Ances et al. 2011). It must be noted, however, that the
groups used for this latter analysis were rather small (six HIV-
positive versus ten HIV-negative subjects). When studying
fluctuations in greater detail, it is important to consider the
effect of different activation in different subgroups
(Rosenblatt et al. 2014) that would require a larger study pop-
ulation. Taken together, the data from these four studies sug-
gest no clear impact of HIVon the characteristics of the BOLD
signal, indicating that differences in BOLD response between
HIV-positive and -negative participants can be interpreted as a
difference in brain activation, i.e., in the amount of neurons
activated in a certain region.
Whole-brain and regions of interest analyses
We analyzed 15 studies focusing on either whole-brain or
region of Interest (ROI) analyses in HIV-positive and -
negative subjects (Tables 3 and 4) (Ernst et al. 2002; Chang
et al. 2001; Schweinsburg et al. 2012; Plessis et al. 2015;
Caldwell et al. 2014; Thomas et al. 2013; Ernst et al. 2009;
Melrose et al. 2008; Chang et al. 2013; Chang et al. 2008;
Maki et al. 2009; Chang et al. 2004; Castelo et al. 2006;
Ortega et al. 2015; Ipser et al. 2015). While whole-brain anal-
yses are used to explore effects throughout the brain, ROI
analyses focus on predefined regions, either anatomically or
by a previous independent study, thereby reducing type I error.
However, when regions are not previously specified but rather
defined based on whole-brain results from the same study, the
chance of bias is drastically increased (Kriegeskorte et al.
2009). Neuropsychological studies have suggested that brain
regions involved in attention, working memory, and episodic
memory may be particularly affected in HIV-positive patients
with HAND (Heaton et al. 2011; Reger et al. 2002; Grant
2008). More recent neuroimaging studies center on fronto-
striatal circuits.
Four of the 15 fMRI studies focused on attention deficits
using visual attention tasks (Ernst et al. 2009; Chang et al.
2013; Chang et al. 2008; Chang et al. 2004). In these tasks,
subjects had to track a certain number of balls among the other
moving balls. Overall, studies reported an increase in
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activation in the attention network (right (pre)frontal and cin-
gulate regions) and/or adjacent structures when attentional
load increased. HIV-positive patients performed at the same
behavioral level (test accuracy and reaction time) as HIV-
negative subjects up until the most difficult tasks. Taken to-
gether, these data suggest that HIV-positive patients show hy-
peractivation of brain regions and/or recruit adjacent regions
to achieve the same behavioral results, up onto the point where
functional brain activation falls short and behavioral results
are affected. Apparently, more neural activation is needed in
the HIV-positive individuals. These analyses suggest that in
HIV-positive subjects, an attention deficit is present which
can, to a certain degree, be counter balanced by the use of
brain reserve capacity (Bosch et al. 2010).
Three studies employed working memory paradigms.
Working memory was tested using a sequential number task,
in which a series of numbers is presented and subjects were
instructed to press a button when the number shown is the
same as n items before. Ernst et al. (2002) and Chang et al.
(2001) found an increase in activation in the lateral prefrontal
cortex and/or parietal regions in the HIV-positive group (Ernst
et al. 2002; Chang et al. 2001). Caldwell et al. (2014) found
that HIV-infected subjects had more activation but similar
accuracy on the simpler tasks but less activation and dimin-
ished accuracy on the more difficult tasks, when compared to
HIV-negative controls (Caldwell et al. 2014).
In addition to the studies investigating attention and work-
ing memory, there were two studies investigating memory
(encoding and recall) (Maki et al. 2009; Castelo et al. 2006).
Maki et al. (2009) and Castelo et al. (2006) used comparable
tasks, in which subjects were instructed to remember either
words or pictures and recall them later. Whole-brain as well as
ROI analyses revealed differences for HIV-positive patients in
activation in hippocampal and/or temporal/frontal cortical
structures. Castelo et al. (2006) found no difference in activity
during encoding and less activity during recognition for HIV-
positive patients, while Maki et al. (2009) found less activity
during encoding and more activity during recognition in HIV-
positive patients. These conflicting results could possibly be
due to the small sample size of both studies (n = 1129 and
n = 2831) and/or the fact that the task used differed slightly.
Furthermore, Castelo et al. (2006) did not provide insight in
the statistical inference used, which makes it more difficult to
interpret their outcomes. In all, despite the limitations, all
memory studies do suggest a dysfunction of hippocampal-
prefrontal regions in HIV-positive subjects, possibly underly-
ing memory deficits.
Four studies centered on the fronto-striatal network. This is
important as frequently occurring symptoms in HAND like
changes in executive functioning suggest a dysfunction in this
circuit (Reger et al. 2002; Sahakian et al. 1995; Wiley et al.
1998). Moreover, a recent meta-analysis found evidence for
hyperactivation in the fronto-striatal circuit in HIV-positive
subjects (Plessis et al. 2014). Melrose et al. (2008) used a
semantic event sequencing task, during which subjects had
to arrange semantic events in the right order (Melrose et al.
2008). They found more activation in the right postcentral/
supramarginal gyrus for the HIV-positive group, while the
HIV-negative groups showed more activation in the frontal
regions. Functional connectivity analyses on resting state data
by Melrose et al. (2008), Thomas et al. (2013), Ortega et al.
(2015), and Ipser et al. (2015) suggested dysfunction between
basal ganglia and other (frontal) regions and less intra- and
internetwork correlations in certain prespecified brain net-
works (Thomas et al. 2013; Melrose et al. 2008; Ortega
et al. 2015; Ipser et al. 2015). This means that even without
using a task, a disturbance could be found between networks
in HIV-positive subjects compared to seronegatives.
Schweinsburg et al. (2012) studied the effect of HIVonmental
rotation, because it is part of the fronto-striatal circuit (Olesen
Table 2 BOLD characteristics
Study HIV/
SN
Region Task Software Threshold Correction M.C. Results
Ances et al. (2011) 6/10 Visual cortex Checker board NR p = 0·05 Mask used HIV + showed reduction in mean
functional BOLD changes over
time and greater inter-subject
variance in BOLD measures




NA No significant difference in BOLD
amplitude between HIV + and −
Juengst et al. (2007) 31/16 HRF Finger tapping NR NA (HRF) NA No significant difference in mean
peak values between HIV +
and HIV−
Ances et al. (2010a) 26/25 Visual cortex Checkerboard AFNI p = 0·05 Yes, not specified HIV+ reduced functional changes
in BOLD signal
AFNI analysis of functional neuroimages, BOLD blood oxygenated level dependent, HIV HIV-positive patients, HRF hemodynamic response function,
M.C. multiple comparisons, NA not applicable, NR not reported, SN seronegative controls
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et al. 2007). They found increased activation in areas of the
postero-parietal cortex pathway and in the left insular and
right occipital cortex, together with less activation in the an-
terior cingulate in HIV-positive subjects (Schweinsburg et al.
2012). Reaction times and accuracy on the fMRI tasks did not
differ between the two groups. Finally, a study by du Plessis
et al. (2014) on fronto-striatal reward processing included only
cART naïve subjects. Using a whole-brain analysis, the study
Table 3 Whole-brain analysis of difference BOLD signal HIV−/+ patients
Study HIV/
SN








FEAT FWE corrected at voxel
level p < 0.05 later
relaxed (not specified)
HIV+ greater activation on the simpler




31/32 Attention Tracking balls SPM2 FWE corrected at voxel
level p < 0.05
HIV+ more activation in right prefrontal











SPM2 Voxel threshold 0.001
uncorrected, small
volume correction
HIV+ less signal change in frontal regions




within the basal ganglia and prefrontal




66/56 Attention Tracking balls SPM8 FWE corrected at cluster
level p < 0.05
HIV+ has load-dependent decreased acti-
vation in right temporal region, while
HIV− showed load-dependent increase
Chang et al.
(2008)
24/10 Attention Tracking balls SPM2 FWE corrected at cluster
level p < 0.05 used
various thresholds
HIV+ has greater load-dependent activa-








SPM99b Voxel threshold 0.001
uncorrected
HIV+ has more BOLD activation in the







SPM99b Voxel threshold 0.001
uncorrected
HIV+ has greater activation in parietal
regions and frontal lobes (lateral




7/4 Memory Encoding task,
recognition
task
SPM2 Cluster corrected (min size
>30) uncorrected
threshold p < 0.05
Encoding: HIV− more activation in
hippocampal and temporal/frontal cor-
tical structures. Recognition: HIV+
more in left superior temporal gyrus,
hippocampus, and right insular cortex
Chang et al.
(2004)
18/18 Attention Tracking balls SPM99b Cluster corrected for M.C.
(not specified)
HIV+ decreased activation in the normal





14/14 Memory Encoding +
recognition
task
SPM99b NR Encoding: no difference. Recognition:
HIV+ less activity in right posterior
hippocampus, right inferior frontal
gyrus, and left lingual gyrus and more









AFNI Cluster corrected multiple
thresholds/cluster size
HIV+ had increased activation in areas of
the PPC-striato-frontal pathway and in
left insular and right occipital cortex






Reward task SPM8 FWE corrected at cluster
level p = 0.05
No between group differences
AFNI analysis of functional neuroimages, BOLD blood oxygen level dependent, FEAT fMRI expert analysis tool, FWE family-wise error,M.C.multiple
comparisons, NR not reported, SPM statistical parametric mapping, PPC postero-parietal cortex
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found no significant difference between cART naïve HIV-
negative and -positive subjects. However, a ROI analysis re-
vealed significant less activation in the ventral striatum during
anticipating neutral or rewarding cues in the latter group. They
did not report differences in the frontal function.
Effect of cART
Only two studies compared functional data between patients
with and without cART (Chang et al. 2008; Ortega et al. 2015)
and one who investigated differences in BOLD signal for
different kinds of cART (Ances et al. 2008). The two papers
studying attention both found a significant difference in
BOLD activation with a greater attentional load-dependent
increase in brain activation for patients on cART and lower
accuracy on the performance of the most difficult task (Ances
et al. 2008; Chang et al. 2008). Ances et al. (2008) found an
increase in the BOLD response for patients on low CNS pen-
etration effectiveness drugs (Ances et al. 2008). Ortega et al.
(2015) found higher functional connections in HIV patients
with cART then HIV patients without cART in fronto-striatal
networks using a functional connectivity analysis.
Effect of aging
Finally, six studies report on the effect of aging on brain func-
tion in HIV-positive and HIV-negative subjects (Table 5)
(Thomas et al. 2013; Ernst et al. 2009; Chang et al. 2013;
Juengst et al. 2007; Ances et al. 2010a; Ipser et al. 2015).
Since HIV patients are aging, it is important to investigate if
aging has an interaction with HIV status on functional data
because both HIVand aging have a degenerative effect on the
brain and functional brain regions. Two studies investigated
the effect of HIV and aging on characteristics of the BOLD
signal and found no interactions (Juengst et al. 2007; Ances
et al. 2010a). Thomas et al. (2013) and Ipser et al. (2015)
calculated functional connectivity during a resting state to
evaluate regional interactions between prespecified functional
Table 4 ROI analysis of differences BOLD signal HIV+/− patients
Study HIV/
SN











Resting state NR FDR corrected
p < 0.05
Yes HIV+ had less intra- and
internetwork correlations in sev-




24/18 Visual attention Tracking balls SPM2 Uncorrected
p = 0.05
No HIV+ load-dependent increase in








Yes HIV+ decreased hippocampal






14/14 Episodic encoding Encoding task,
recognition task
SPM99b Not reported Both HIV+ had attenuated activation of
brain regions known to support
episodic encoding (right
posterior hippocampus, left and
right lingual gyrus, right inferior











Reward task SPM8 no Yes HIV+ decrease in activation in
ventral striatum for anticipating







Resting state FS-FAST FDR corrected
p = <0.05
Yes HIV+ had lower cortico-striatal
functional connectivity. HIV+







Resting state AFNI Not reported Yes HIV+ had reductions in
connectivity in fronto-striatal re-
gions.
AFNI analysis of functional neuroimages, FDR false discovery rate, FS-FAST freesurfer functional analysis stream, MC multiple comparisons, NR not
reported, ROI region of interest, SPM statistical parametric mapping
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networks. They found similar decreases in correlations be-
tween networks with aging and HIV infection, but there was
no interaction between HIV and aging (Thomas et al. 2013;
Ipser et al. 2015). Ernst et al. (2009) and Chang et al. (2013)
used the same visual attention task (Ernst et al. 2009; Chang
et al. 2013). The longitudinal study by Ernst et al. (2009)
found that after 1 year follow-up, HIV-positive subjects had
more activation in the right prefrontal and posterior parietal
cortices and bilateral cerebellum than HIV-negative subjects
(Ernst et al. 2009). A possible explanation is a learning effect
in the HIV-negative group or an effect of ongoing brain injury
in the HIV-positive group. Chang et al. (2013) also reported
interactions between age and HIV status with greater age-
related increase in activation in various regions (Chang et al.
2013). Noting that from the five studies, only one found an
interaction with HIVand aging; the limited evidence seems to
point towards there being no interaction between these param-
eters. We therefore decided to regard them as independent
factors.
Discussion
This systematic review of 17 studies describes the effect of
HIV infection on brain function as measured by BOLD fMRI.
Overall, HIV does not seem to alter BOLD characteristics.
This is important, as this finding suggests that the coupling
between neural activation and the BOLD response itself is not
necessarily different in HIV-positive patients. A difference in
BOLD response is therefore attributable to a difference in the
amount of neural activation. The majority of studies found
that for completing the same task, HIV-positive patients
showed more activation or recruited more regions when com-
pared to HIV-negative controls. Although there is a large va-
riety in the study design, studied populations, and levels of
statistic inferences, most evidence seems to point to affected
fronto-striatal function. There appears to be no or limited in-
teraction between HIV status and aging on functional neuro-
imaging data, although there are few longitudinal studies.
Finally, the effect of cART on brain function is not yet been
adequately addressed.
Since its introduction in the 1990s, fMRI has been proven
to be a very sensitive instrument, with an even greater ability
to detect functional brain abnormalities than neuropsycholog-
ical assessment (Haley et al. 2011; Saykin et al. 1999;
Sumowski et al. 2012). Neuropsychological studies have
shown that HIV seems to predominantly affect the fronto-
striatal network (Grant 2008; Ellis et al. 2007; Woods et al.
2009). This network consists of neural pathways that connect
frontal regions with the basal ganglia, and these circuits are,
Table 5 BOLD signal differences HIV+/− patients combined with aging effect











NR ROI FDR corrected
threshold of
0.05
Aging causes decrease in intranetwork
correlations in DMN and SAL and
internetwork correlations between




31/32 Visual attention Tracking balls SPM2 ROI FWE corrected
at voxel level
p < 0.05
After 1 year, HIV+ more BOLD signal in
right prefrontal and posterior parietal
cortices and cerebellum bilaterally.
HIV− less BOLD signal after 1 year
Chang et al.
(2013)
66/56 Visual attention Tracking balls SPM8 WB FWE corrected
at cluster
p < 0.05
HIV+ had greater age-related increases in
brain activation in right parietal, cin-
gulate and paracentral regions, cere-




31/16 HRF Finger tapping NR WB NA (HRF) No effect or interaction with HIV status
for age in mean BOLD peak value
Ances et al.
(2010b)




HIVand increasing age independently







Resting state AFNI ROI Not reported Reduction in connectivity in individuals
over 50 years, no interaction between
age and HIV
AFNI analysis of functional neuroimages, BOLD blood oxygen level dependent, DMN default mode network, FDR false discovery rate, FWE family-
wise error, HRF hemodynamic response function, M.C. multiple comparisons, NR not reported, ROI region of interest analysis, SAL salience network,
SPM statistical parametric mapping, VOI volume of interest analysis, WB whole-brain analysis
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among other things, involved in executive functioning (Plessis
et al. 2014; Grant 2008; Watkins and Treisman 2015). This
systematic review confirms these neuropsychological test ob-
servations by showing that impairment of the fronto-striatal
system was more pronounced in HIV-positive versus HIV-
negative patients. This is consistent with previous literature
(Plessis et al. 2014). It is important to note that studies in this
review suggest that, even without clinical symptoms or neu-
ropsychological abnormalities, a functional impairment exists
in the brains of HIV patients. One explanation for this occur-
rence is the so-called brain reserve theory, where patients use a
hyperactivation or activation of adjacent structures, thus more
neural effort to achieve the same behavioral results (Holt et al.
2012). Compared to controls, HIV-positive participants show
an overall comparable behavioral performance though perfor-
mance in behavioral outcomes is poor for the more difficult
tasks.
It appears that HIV patients use hyperactivation of brain
regions and recruitment of additional brain regions tomaintain
the same behavioral score, but this mechanism falls short
when performing the more difficult tasks. It appears that this
hyperactivation is inefficient, possibly due to interfering pro-
cesses related to the HIV infection. There are several theories
of how HIV infection results in functional impairment: first of
all, the virus itself, which enters the central nervous system
(CNW) within days after infection (Davis et al. 1992;
González-Scarano et al. 2005). There is no evidence that
HIV actually infects or damages neurons, but due to specific
viral proteins produced by infected cells such as gp120, Tat, or
Vpr, subsequent local damage can be done (Price et al. 1988).
The neurotoxicity theory by HIV is supported by the fact that
starting combination antiretroviral therapy often greatly im-
proves the cognitive ability of patients suffering from HAD
(Price and Spudich 2008). However, even in patients receiving
adequate antiretroviral therapy, cognitive decline can still oc-
cur (McArthur et al. 2004). Perhaps, the compartmentalization
of HIV in the CNS and the accompanying local ongoing
neuro-inflammation or the sensitizing of the immune system
by the virus might be an explanation for this observation
(Schouten et al. 2011; Campillo-Gimenez et al. 2014).
Furthermore, the effect of the virus has been compared to
the neurodegenerative process seen in aging. However, the
four papers in this systematic review investigating aging and
HIV suggest that there is no or limited interaction between
HIV status and aging and that they are independent factors
to consider.
Antiretroviral drugs are another potential important cause
for cognitive disorders in HIV-positive patients. With the re-
cently published INSIGHT STARTstudy in mind, it is recom-
mended to start cARTeven in patients with CD4-counts above
500 cells per cubic millimeter (Initiation of Antiretroviral
2015). Subsequently, this will lead to more patients on therapy
and therefore it thus remains of importance to investigate the
(sub)clinical and possible long-term consequences of contin-
ual antiretroviral therapy on cognition. One of the drugs often
implicated in decreased cognitive functioning, is Efavirenz
(Ciccarelli et al. 2011). For example, a recent study on treat-
ment interruption found an improvement in cognition as mea-
sured by neuropsychological assessment (NPA) after cessa-
tion of therapy (Robertson et al. 2010). Additionally, the au-
thors found a difference in improvement after discontinuing
different cART regimes, with cessation of Efavirenz contain-
ing regimes giving the most effect. Indeed, the effect of cART
on cognitive performance has been described before, with
Efavirenz as the most significant example (Clifford et al.
2005). Studies in this review showed that patients on cART
use more of their brain reserve, and the type of cART affects
the BOLD response. This suggests a possible effect of medi-
cation and the type of medication on cognition in HIV pa-
tients. Based on the results of this systematic review, function-
al MRI appears to be an appropriate tool to detect subtle cog-
nitive changes. There are, however, very few studies investi-
gating the effects of chronic cART on the CNS. Recently,
another South African study in cART naïve HIV-positive pa-
tients investigating the fronto-striatal network using an inhibi-
tion task was published, showing subcortical dysfunction (du
Plessis et al. 2015). Currently, a randomized longitudinal
study is underway utilizing fMRI to estimate the effect of
Efavirenz on cognition (clinicaltrials.gov NCT02308332).
Another important consideration in this review is the
used of statistical and analytical methods used in various
studies. First, most studies included only small numbers of
patients sometimes hampering firm conclusions. Another
problem is statistical inference. Following improvements
in fMRI analysis techniques and software, statistical and
methodological issues have become less of a problem dur-
ing recent years. For example, the earliest studies did not
properly correct for multiple comparisons (Ernst et al.
2009; Chang et al. 2004; Castelo et al. 2006) or proper
thresholding (Chang et al. 2008; Castelo et al. 2006) while
more recently published studies tend to have better meth-
odological quality (Plessis et al. 2015; Thomas et al. 2013;
Chang et al. 2013). Another limitation is that studies in-
cluded in this review all described a very Bclean^ popula-
tion, i.e., dominantly male participants, with ages between
30 and 50, and lacking information on comorbidities, co-
infections, or previous cART regimes. Therefore, no con-
clusions could be drawn regarding the effect of these fac-
tors on functional brain imaging. It is important for future
fMRI studies to include younger patients or those with
comorbidities or co-medication. Furthermore, different
tasks used in these studies make generalizability of results
more difficult and need to be addressed in future study
designs. The use of longitudinal studies is mandatory since
they can aid in exploring the use of fMRi in detecting early
changes before clinical symptoms.
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Summarizing, when compared with HIV-negative subjects,
HIV-positive patients showed a hyperactivation of brain re-
gions, suggesting a so-called brain reserve theory, when in-
vestigating regions involved in attention, (working) memory,
and executive functioning, with the most evidence pointing to
defects in fronto-striatal pathways. Increasing age has a com-
parable effect on brain function, but it does not interact with
HIV status. Limited data points to an effect of cART on brain
function. Further research is needed to confirm this effect.
In conclusion, fMRI is a sensitive instrument to detect
changes in brain activation associated with subtle cognitive
changes in HIV patients.
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